San Diego – March 29, 2017 – Cooley advised the underwriters in Vital Therapies’ $40.3 million follow-on offering of 10,062,500 shares of common stock, which includes the full exercise of the underwriters’ option to purchase an additional 1,312,500 shares.
Raymond James & Associates acted as book-running manager for the offering and National Securities Corporation acted as co-manager.
Vital Therapies, which is based in San Diego and trades on The NASDAQ Global Select Market as “VTL,” is a biotherapeutic company focused on developing a cell-based therapy targeting the treatment of acute forms of liver failure.
Cooley also advised the underwriters on Vital Therapies’ IPO in April 2014.
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 900 lawyers across 12 offices in the United States, China and Europe.